Clinical Trial Update: INS316 in Diagnosing Lung Cancer in Patients With Untreated Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating INS316 for diagnosing lung cancer in patients with untreated lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• INS316

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED